The evolution of microbiology testing within contamination control strategies reflects broader changes across the ...

Affinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, announces that its CyPath® Lung test will be featured at the ...

Liquid biopsy technologies, particularly circulating tumor DNA, or ctDNA, are changing how clinicians monitor hematologic ...

The FDA proposes MRD negativity as an accelerated approval end point to speed access to novel myeloma therapies.

Primary immunodeficiencies (PIDs) represent a diverse group of disorders stemming from genetic mutations that compromise ...

With two decades of dedicated focus in this field, Cloud-Clone has evolved from early-stage exploration into a globally ...

Fat hits the gut fast, and one line of immune defense disappears almost right away. That is the unsettling picture from a new ...

Cue Biopharma, Inc. ( CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases April 7, 2026 10:00 AM EDT Lucinda Warren - Interim CEO, Interim President,Principal ...

H-funded project will build a decision-making tool to help drugmakers and regulators predict treatments likely to work best ...

SNS Insider reported that global Flow Cytometry Market was valued at USD 5.75 billion in 2025 and is expected to reach USD 12.19 billion by 2035, growing at a CAGR of 7.8% over the forecast period of ...

A team of researchers at the Georgia Institute of Technology and Emory University has developed a deep-ultraviolet (UV) ...

Connecting research skills academic scientists already have can help them explore and transition to new careers.